Among the many products claiming to help with weight loss, a new formula has emerged: Fitspresso. Fitspresso is marketed as a ...

Eli Lilly will start studying its obesity products as treatments for alcohol and drug abuse, making it the first major ...

Eli Lilly strikes Zepbound deal with the telehealth platform Ro, amid questions about future of compounded GLP-1s.

In today’s fast-paced world, maintaining a healthy weight can be a daunting task. With countless weight loss products ...

In the ever-evolving landscape of weight loss solutions, Mitolyn emerges as a remarkable contender, capturing the attention ...

As demand for obesity drugs like Wegovy, Zepbound, Mounjaro and Ozempic, outpaces supply, online scams are rising, according to cybersecurity experts.

Eli Lilly said patients taking its obesity drug Zepbound lost 47% more weight than those who were given Novo Nordisk's Wegovy ...

Attention deficit hyperactivity disorder (ADHD) impacts the ability to maintain attention to tasks. Often, it also involves impulsive behaviour ...

Even as weight-loss drugs such as Wegovy and Zepbound explode in popularity, many Americans struggle to afford them.

Ozempic is, however, expensive. Currently, its most palpable cultural effect is the stark inequality of access. In Canada, a ...

Ritalin is a drug used mainly to treat attention-deficit/hyperactivity disorder (ADHD), but what are its risks? Here, you ...